UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Acta neuropathologica, 2021-02, Vol.141 (2), p.291-301

2021

Volltextzugriff (PDF)

Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial

Neuro-oncology (Charlottesville, Va.), 2019-10, Vol.21 (10), p.1319-1330

2019

Volltextzugriff (PDF)

Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor

Journal of clinical oncology, 2009-01, Vol.27 (3), p.385-389

2009

Volltextzugriff (PDF)

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

Neuro-oncology (Charlottesville, Va.), 2023-02, Vol.25 (2), p.386-397

2023

Volltextzugriff (PDF)

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Pediatric blood & cancer, 2014-04, Vol.61 (4), p.636-642

2014

Volltextzugriff (PDF)

Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma

Journal of clinical oncology, 2019-04, Vol.37 (12), p.974-983

2019

Volltextzugriff (PDF)

Multiple pilomatrixomas in a survivor of WNT‐activated medulloblastoma leading to the discovery of a germline APC mutation and the diagnosis of familial adenomatous polyposis

Pediatric blood & cancer, 2018-01, Vol.65 (1), p.n/a

2018

Volltextzugriff (PDF)

Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database

PloS one, 2019-09, Vol.14 (9), p.e0223051-e0223051

2019

Volltextzugriff (PDF)

Medical Cannabis Certification in a Large Pediatric Oncology Center

Children (Basel), 2019-06, Vol.6 (6), p.79

2019

Volltextzugriff (PDF)

Correction: Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database

PloS one, 2019-10, Vol.14 (10), p.e0224570-e0224570

2019

Volltextzugriff (PDF)

Effects of proactive and rescue enteral tube feedings on weight change in children undergoing treatment for high-grade CNS tumors

Neuro-oncology practice, 2020-08, Vol.7 (4), p.428-438

2020

Volltextzugriff (PDF)

QOL-13. ESTABLISHMENT OF A REHABILITATION CLINICAL SPECIALIST IN ONCOLOGY SIGNIFICANTLY IMPROVED REHABILITATION ACCESS FOR PEDIATRIC NEUROONCOLOGY PATIENTS: A SINGLE INSTITUTION EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i160-i160

2018

Volltextzugriff (PDF)

Sleep in children with neoplasms of the central nervous system: case review of 14 children

Pediatrics (Evanston), 2003-07, Vol.112 (1 Pt 1), p.e46

2003

Volltextzugriff (PDF)

LGG-63 MEK inhibitor-associated retinopathy (MEKAR) in a pediatric patient with an optic pathway glioma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i102-i103

2022

Volltextzugriff (PDF)

Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in Ewing family of tumors

Annals of clinical and laboratory science, 2009, Vol.39 (2), p.160-166

2009

Volltextzugriff (PDF)

MDB-48. A SINGLE INSTITUTION EXPERIENCE OF CIPN MEASURED BY THE PED-MTNS IN CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA TREATED ON A TRIAL USING SIMILAR DOSING OF VINCRISTINE AND CISPLATIN FOR ALL PATIENTS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

OTHR-29. A SINGLE INSTITUTION REVIEW REGARDING TRENDS IN THE MOLECULAR ANALYSIS OF PEDIATRIC CENTRAL NERVOUS SYSTEM (CNS) TUMORS AND GERMLINE ANALYSIS BETWEEN 2019 – 2023, EMPHASIZING THE IMPORTANCE OF EASY ACCESS TO COMPREHENSIVE TESTING

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

OTHR-46. Single institution experience using molecular analysis of pediatric CNS tumors

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i157-i157

2022

Volltextzugriff (PDF)

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

Nature genetics, 2014-05, Vol.46 (5), p.451-456

2014

Volltextzugriff (PDF)

Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children

Neuro-oncology (Charlottesville, Va.), 2015-06, Vol.17 (6), p.882-888

2015

Volltextzugriff (PDF)

LGG-36. DESMOPLASTIC INFANTILE GANGLIOGLIOMA (DIG) WITH A PPP1CB-ALK FUSION IN A 6-YEAR-OLD GIRL

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Supplement_3), p.iii373-iii373

2020

Volltextzugriff (PDF)

ATRT-04. LATE DEVELOPMENT OF METACHRONOUS ATYPICAL TERATOID/RHABDOID TUMORS (AT/RTS) OR MALIGNANT RHABDOID TUMOR (MRT) IN THREE PATIENTS WITH GERMLINE SMARCB1 MUTATIONS

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i27-i28

2018

Volltextzugriff (PDF)

Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor

Oncotarget, 2017-09, Vol.8 (41), p.69295-69302

2017

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials

Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial

Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma

Multiple pilomatrixomas in a survivor of WNT‐activated medulloblastoma leading to the discovery of a germline APC mutation and the diagnosis of familial adenomatous polyposis

Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database

Medical Cannabis Certification in a Large Pediatric Oncology Center

Correction: Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database

Effects of proactive and rescue enteral tube feedings on weight change in children undergoing treatment for high-grade CNS tumors

QOL-13. ESTABLISHMENT OF A REHABILITATION CLINICAL SPECIALIST IN ONCOLOGY SIGNIFICANTLY IMPROVED REHABILITATION ACCESS FOR PEDIATRIC NEUROONCOLOGY PATIENTS: A SINGLE INSTITUTION EXPERIENCE

Sleep in children with neoplasms of the central nervous system: case review of 14 children

LGG-63 MEK inhibitor-associated retinopathy (MEKAR) in a pediatric patient with an optic pathway glioma

Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in Ewing family of tumors

MDB-48. A SINGLE INSTITUTION EXPERIENCE OF CIPN MEASURED BY THE PED-MTNS IN CHILDREN AND ADOLESCENTS WITH MEDULLOBLASTOMA TREATED ON A TRIAL USING SIMILAR DOSING OF VINCRISTINE AND CISPLATIN FOR ALL PATIENTS

OTHR-29. A SINGLE INSTITUTION REVIEW REGARDING TRENDS IN THE MOLECULAR ANALYSIS OF PEDIATRIC CENTRAL NERVOUS SYSTEM (CNS) TUMORS AND GERMLINE ANALYSIS BETWEEN 2019 – 2023, EMPHASIZING THE IMPORTANCE OF EASY ACCESS TO COMPREHENSIVE TESTING

OTHR-46. Single institution experience using molecular analysis of pediatric CNS tumors

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children

LGG-36. DESMOPLASTIC INFANTILE GANGLIOGLIOMA (DIG) WITH A PPP1CB-ALK FUSION IN A 6-YEAR-OLD GIRL

ATRT-04. LATE DEVELOPMENT OF METACHRONOUS ATYPICAL TERATOID/RHABDOID TUMORS (AT/RTS) OR MALIGNANT RHABDOID TUMOR (MRT) IN THREE PATIENTS WITH GERMLINE SMARCB1 MUTATIONS

Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor

Suchergebnisse filtern